Bright Green Corp. (BGXX) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bright Green Corporation has announced their successful acquisition of final approval from the New Mexico Board of Pharmacy and the DEA, granting them the ability to engage in research, production, and manufacturing involving Schedule I and II plant-based drugs and APIs. This pivotal development marks a significant milestone for the company, potentially impacting its position in the pharmaceutical and biotech sectors.
For further insights into BGXX stock, check out TipRanks’ Stock Analysis page.